Literature DB >> 22281099

Dependence scores predict prognosis of medication overuse headache: a prospective cohort from the Akershus study of chronic headache.

Christofer Lundqvist1, Ragnhild Berling Grande, Kjersti Aaseth, Michael Bjørn Russell.   

Abstract

Medication overuse headache (MOH) is a chronic headache that is common in the general population. It has characteristics similar to drug dependence, and detoxification is established as the main treatment. The majority of MOH cases are in contact with general practitioners. Our objective was to investigate whether the Severity of Dependence Scale (SDS) score could be used as predictor for the prognosis of MOH in the general population. In a cross-sectional epidemiological survey, an age- and gender-stratified sample of 30,000 persons 30 to 44 years of age was recruited via a posted questionnaire. Those individuals with self-reported chronic headache (≥15 days per month) were interviewed by neurological residents at Akershus University Hospital, Oslo. The International Classification of Headache Disorders was used. Those with MOH were re-interviewed by telephone 2 to 3 years after the initial interview. SDS scores and medication information were collected at baseline and follow-up. The main outcomes were SDS scores, termination of MOH and chronic headache from baseline to follow-up. We found the predominant overused analgesics in this sample to be simple analgesics. At follow-up, 65% of participants no longer had medication overuse, and 37% had changed to episodic headache (<15 days per month). The SDS score at baseline successfully predicted improvement for primary MOH, but not secondary MOH. The SDS scores decreased slightly from baseline to follow-up in those who stopped medication overuse, but were still significantly higher than in subjects with chronic headache without medication overuse at baseline. We conclude that the SDS score can predict successful prognosis related to detoxification of primary MOH but not in secondary MOH. Copyright Â
© 2011 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22281099     DOI: 10.1016/j.pain.2011.12.008

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  12 in total

Review 1.  Medication-overuse headache: epidemiology, diagnosis and treatment.

Authors:  Espen Saxhaug Kristoffersen; Christofer Lundqvist
Journal:  Ther Adv Drug Saf       Date:  2014-04

2.  Decrease of gray matter volume in the midbrain is associated with treatment response in medication-overuse headache: possible influence of orbitofrontal cortex.

Authors:  Franz Riederer; Andreas R Gantenbein; Marvin Marti; Roger Luechinger; Spyridon Kollias; Peter S Sándor
Journal:  J Neurosci       Date:  2013-09-25       Impact factor: 6.167

3.  Psychological and neuropsychological correlates of dependence-related behaviour in medication overuse headaches: a one year follow-up study.

Authors:  Françoise Radat; Sandra Chanraud; Georges Di Scala; Virginie Dousset; Michèle Allard
Journal:  J Headache Pain       Date:  2013-07-04       Impact factor: 7.277

Review 4.  Medication-overuse headache: a review.

Authors:  Espen Saxhaug Kristoffersen; Christofer Lundqvist
Journal:  J Pain Res       Date:  2014-06-26       Impact factor: 3.133

5.  Dependency-like behaviors and pain coping styles in subjects with chronic migraine and medication overuse: results from a 1-year follow-up study.

Authors:  Bruno Biagianti; Licia Grazzi; Susanna Usai; Orsola Gambini
Journal:  BMC Neurol       Date:  2014-09-19       Impact factor: 2.474

6.  Chiropractic spinal manipulative therapy for cervicogenic headache: a study protocol of a single-blinded placebo-controlled randomized clinical trial.

Authors:  Aleksander Chaibi; Jūratė Šaltytė Benth; Peter J Tuchin; Michael Bjørn Russell
Journal:  Springerplus       Date:  2015-12-16

Review 7.  Prognostic factors for chronic headache: A systematic review.

Authors:  Katrin Probyn; Hannah Bowers; Fiona Caldwell; Dipesh Mistry; Martin Underwood; Manjit Matharu; Tamar Pincus
Journal:  Neurology       Date:  2017-06-14       Impact factor: 9.910

8.  Study protocol: brief intervention for medication overuse headache--a double-blinded cluster randomised parallel controlled trial in primary care.

Authors:  Espen Saxhaug Kristoffersen; Jørund Straand; Jūratė Saltytė Benth; Michael Bjørn Russell; Christofer Lundqvist
Journal:  BMC Neurol       Date:  2012-08-10       Impact factor: 2.474

9.  Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): a prospective, randomized, open-label trial.

Authors:  Paolo Rossi; Jessica Veronica Faroni; Cristina Tassorelli; Giuseppe Nappi
Journal:  J Headache Pain       Date:  2013-02-08       Impact factor: 7.277

10.  Chiropractic spinal manipulative therapy for migraine: a study protocol of a single-blinded placebo-controlled randomised clinical trial.

Authors:  Aleksander Chaibi; Jūratė Šaltytė Benth; Peter J Tuchin; Michael Bjørn Russell
Journal:  BMJ Open       Date:  2015-11-19       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.